Prophase labs, inc. (PRPH)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Net sales

9,876

13,126

9,867

4,206

2,518

22,070

25,032

22,406

17,453

14,502

19,816

Cost of sales

7,261

8,345

7,919

3,209

1,686

7,891

8,361

8,154

6,171

5,672

8,247

Gross profit

2,615

4,781

1,948

997

832

14,179

16,671

14,252

11,282

8,830

11,569

Operating expenses:
Sales and marketing

1,042

1,107

699

1,700

303

8,965

9,538

8,946

7,904

5,576

4,852

Administration

4,480

4,910

4,808

2,733

2,267

8,143

5,893

6,127

5,028

6,054

9,344

Research and development

332

398

431

358

340

1,322

824

1,301

1,088

794

1,308

Impairment charge (Note 10)

-

-

-

-

-

3,577

0

0

-

-

-

Settlement benefit (Note 5)

-

-

-

-

-

-

-

1,024

0

0

-

Total operating expenses

5,854

6,415

5,938

4,791

2,910

22,007

16,255

15,350

14,020

12,424

15,504

Loss from operations

-3,239

-1,634

-3,990

-

-

-7,828

416

-1,098

-2,738

-3,594

-3,935

Interest income, net

133

167

177

1

2

4

2

-

-

-

-

Other income

-

-

150

0

0

-

-

-

-

-

-

Interest expense

-

-

-

213

18

10

13

0

0

-

-

Total interest and other income

-

-

327

-212

-16

-

-

7

28

53

9

Loss from continuing operations before income taxes

-3,106

-1,467

-3,663

-4,006

-2,094

-7,834

405

-1,091

-2,710

-3,541

-3,926

Income tax liability from continuing operations

-

103

-1,421

0

0

0

0

0

0

-40

-84

Loss from continuing operations

-3,106

-1,570

-2,242

-4,006

-2,094

-

-

-

-

-

-

Discontinued operations:
Income from discontinued operations

-

-

-530

-1,138

1,506

-

-

-

-

-

-

Loss on discontinued operations, net of taxes

-40

-170

42,301

0

0

-

-

-

-

-

-

Loss from discontinued operations

-40

-170

42,831

1,138

-1,506

-

-

-

-

-

-

Net loss

-3,146

-1,740

40,589

-2,868

-3,600

-7,834

405

-1,091

-2,710

-3,501

-3,842

Other comprehensive income:
Unrealized gain on marketable debt securities

22

54

-78

0

0

-

-

-

-

-

-

Total comprehensive loss

-3,124

-1,686

40,511

-2,868

-3,600

-

-

-

-

-

-

Basic and diluted loss per share:
Loss from continuing operations

-

-

-0.14

-0.24

-0.13

-

-

-

-

-

-

Income (loss) from discontinued operations

-

-

2.75

0.07

-0.09

-

-

-

-

-

-

Net loss

-

-

2.61

-0.17

-0.22

-

0.03

-

-

-

-

Loss from continuing operations

-

-

-0.14

-0.24

-0.13

-

-

-0.07

-0.18

-

-

Income (loss) from discontinued operations

-

-

2.73

0.07

-0.09

-

-

-

-

-

-

Net loss

-

-

2.59

-0.17

-0.22

-

0.03

-

-

-

-

Loss from continuing operations

-0.27

-0.14

-

-

-

-

-

-0.07

-0.18

-

-

Loss from discontinued operations

-

-0.01

-

-

-

-

-

-

-

-

-

Basic and diluted loss per share:

-0.27

-0.15

-

-

-

-0.47

-

-

-

-0.25

-0.30

Weighted average common shares outstanding:
Basic and diluted

11,564

11,396

-

-

-

16,773

-

-

-

-

-

Basic

-

-

15,565

17,081

16,398

-

15

14,843

14,817

-

-

Diluted

-

-

15,696

17,081

16,398

-

16

14,843

14,817

-

-

Basic and diluted (in shares)

-

-

-

-

-

-

-

-

-

14

12,963